ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Quality of Supraclavicular, Infraclavicular and Axillary Approach of Ultrasound-guided Brachial Plexus Block

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01442558
Recruitment Status : Completed
First Posted : September 28, 2011
Last Update Posted : January 21, 2015
Sponsor:
Information provided by (Responsible Party):
Hillel Yaffe Medical Center

Brief Summary:
The aim of this study is to compare the quality of 3 methods of ultrasound-guided brachial plexus blocks for surgical anesthesia

Condition or disease Intervention/treatment Phase
Pain Drug: Bupivacaine Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 101 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Study Start Date : December 2011
Actual Primary Completion Date : September 2013
Actual Study Completion Date : September 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: SCL
Supraclavicular ultrasound-guided brachial plexus block
Drug: Bupivacaine
Bupivacaine 5 mg/cc with adrenaline 5 mcg/cc will be injected with complete spread of the drug around nerves.
Active Comparator: ICL
Infraclavicular ultrasound-guided brachial plexus block
Drug: Bupivacaine
Bupivacaine 5 mg/cc with adrenaline 5 mcg/cc will be injected with complete spread of the drug around nerves.
Active Comparator: AX
Axillary ultrasound-guided brachial plexus block
Drug: Bupivacaine
Bupivacaine 5 mg/cc with adrenaline 5 mcg/cc will be injected with complete spread of the drug around nerves.



Primary Outcome Measures :
  1. Quality of 3 different approaches to brachial plexus block [ Time Frame: Immediate ]
    Whether or not there is need for additional analgesic drugs or need to switch to general anesthesia



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • ASA I-III physical status
  • Surgery of distal arm, forearm or hand

Exclusion Criteria:

  • Skin infection near block injection site
  • Allergy to local anesthetics
  • Peripheral neuropathy upper limb
  • INR of more than 1.4
  • Thrombocytopenia
  • Opioid dependency
  • Chronic pain syndrome
  • Lack of orientation to person, place and time
  • Patient refusal

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01442558


Locations
Israel
Hillel Yaffe Medical Center
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01442558     History of Changes
Other Study ID Numbers: 0081-2011-HYMC
First Posted: September 28, 2011    Key Record Dates
Last Update Posted: January 21, 2015
Last Verified: September 2011

Keywords provided by Hillel Yaffe Medical Center:
relief
Intra-operative

Additional relevant MeSH terms:
Bupivacaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents